PIK3CD and cancer: The PI3Ks/Akt/mTOR pathway is a well-established target for anti-cancer drugs development [97,98,120,121,122,123,124,125] and several inhibitors have been developed, targeting PI3K, Akt, mTOR, as represented very schematically in Figure 3.